Hedley James A, Vajdic Claire M, Wyld Melanie, Waller Karen M J, Kelly Patrick J, De La Mata Nicole L, Rosales Brenda M, Wyburn Kate, Webster Angela C
Collaborative Centre for Organ Donation Evidence, Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Cancer Epidemiology Research Unit, Centre for Big Data Research in Health, University of New South Wales, Kensington, NSW, Australia.
Transpl Int. 2021 Sep;34(9):1667-1679. doi: 10.1111/tri.13989.
Evidence on cancer transmission from organ transplantation is poor. We sought to identify cases of cancer transmission or non-transmission from transplantation in an Australian cohort of donors and recipients. We included NSW solid organ deceased donors 2000-2012 and living donors 2004-2012 in a retrospective cohort using linked data from the NSW Biovigilance Register (SAFEBOD). Central Cancer Registry (CCR) data 1972-2013 provided a minimum one-year post-transplant follow-up. We identified cancers in donors and recipients. For each donor-recipient pair, the transmission was judged likely, possible, unlikely, or excluded using categorization from international guidelines. In our analysis, transmissions included those judged likely, while those judged possible, unlikely, or excluded were non-transmissions. In our cohort, there were 2502 recipients and 1431 donors (715 deceased, 716 living). There were 2544 transplant procedures, including 1828 (72%) deceased and 716 (28%) living donor transplants. Among 1431 donors, 38 (3%) had past or current cancer and they donated to 68 recipients (median 6.7-year follow-up). There were 64 (94%) non-transmissions, and 4 (6%) transmissions from two living and two deceased donors (all kidney cancers discovered during organ recovery). Donor transmitted cancers are rare, and selected donors with a past or current cancer may be safe for transplantation.
关于器官移植导致癌症传播的证据不足。我们试图在澳大利亚的一组捐赠者和接受者中识别移植导致癌症传播或未传播的病例。我们利用新南威尔士州生物警戒登记册(SAFEBOD)的关联数据,将2000 - 2012年新南威尔士州实体器官已故捐赠者以及2004 - 2012年活体捐赠者纳入回顾性队列研究。1972 - 2013年中央癌症登记处(CCR)的数据提供了移植后至少一年的随访信息。我们确定了捐赠者和接受者中的癌症病例。对于每一对捐赠者 - 接受者,根据国际指南的分类判断传播可能性为很可能、有可能、不太可能或排除。在我们的分析中,传播包括那些被判断为很可能的情况,而那些被判断为有可能、不太可能或排除的则为未传播。在我们的队列中,有2502名接受者和1431名捐赠者(715名已故,716名活体)。有2544例移植手术,包括1828例(72%)已故捐赠者移植和716例(28%)活体捐赠者移植。在1431名捐赠者中,38名(3%)曾患或患有癌症,他们捐赠给了68名接受者(中位随访6.7年)。有64例(94%)未传播,4例(6%)传播来自两名活体和两名已故捐赠者(所有肾癌均在器官获取时发现)。捐赠者传播的癌症很罕见,选择有既往或当前癌症的特定捐赠者进行移植可能是安全的。